References
- Andersen H., Möller K., Simesen M. Über die Zustandsform von Sulfathiazol im Blut, Urin und in der Cerebrospinalflüssigkeit. Arch. exp. Path. u. Pharm 1942; 199: 528
- Andersen H., Simesen M. Über den Übergang von Sulfathiazol, Sulfapyridin und Sulfamethylthiazol von der Mutter zum Fötus. Arch. intern. Med. Livingstone, Edinburgh & London 1963; 199: 521, Barber & Garrod: Antibiotics and Chemotherapy
- Blanc W. A., Johnson L. Studies on kernicterus. J. Neuropath, exp. Neurol 1959; 18: 165
- Boger W., Strickland C., Gylfe J. Sulfa-methoxypyridazine (Kynex), a new long-acting sulfonamide. Antihiot. Med 1956; 3: 378
- Dettli L., Baur M., Spring P. Über die Ei-weissbindung der Sulfanilamide in vitro und in vivo. Chemotcrapia 1963; 6: 195
- Fichter E., Curtis J. Sulfonamide administration in newborn and premature infants. Pediatrics 1956; 18: 50
- Frisk R. Sulfanilamide derivatives. Chemothera-peutic evaluation of N'-substituted sulfanil-amides. Acta med. scand. Suppl 1943; 142
- Andersen H., Holmgård å. Comparative clinical evaluation of sulfaphenazole, sulfadimetboxine and sulfamethoxypyridazine. Antibiot. Ann 1959–1960; 7: 868
- Harris P., Riley H., Knight V. Sulfamethoxy-pyridazine in urinary tract infections. Arch. intern. Med 1957; 100: 701
- Harris R. C, Lucey J. F., MacLean J. R. Kernicterus in premature infants associated with low concentrations of bilirubin in the plasma. Pediatrics 1958; 21: 875
- Holmgård å., Josephson B., Bucht H., Örsten P. å. A new sulfonamide combination designed for treatment of kidney and urinary tract infections. Curr. ther. Res 1961; 3: 397
- Jackson G. G., Grieble H. Sulfamethoxypyridazine: pharmacological observations and clinical use in the treatment of urinary tract infections. Ann. N.Y. Acad. Sci 1957; 69: 493
- Johnson L., Blanc W. A., Lucey J. F., Day R. Kernicterus in rats with familial jaundice. Amer. J. Dis. Child 1957; 94: 548
- Andersen H., Sarmiento F., Blanc W. A., Day R. Kernicterus in rats with an inherited deficiency of glucuronyl transferase. J. Dis. Child 1959; 97: 591
- Kayser H. W. Sulfonamidwirkung auf Mutter und Kind unter der Geburt. Klin. Wschr 1941; 20: 510
- Lindahl O., Josephson B. The kidney function and the renal clearance of some sulfanil-amide derivatives. Acta med. scand 1945; 120, fasc. III—IV
- Martin N. H. Preparation and properties of serum and plasma proteins XXI. Interactions with bilirubin. J. Amer. client. Soc 1949; 71: 1230
- Newbould B. B., Kilpatrick R. Long-acting sulphonamides and proteinbinding. Lancet 1960; I: 887
- Nosslin B. The direct diazo reaction of bile pigments in serum. Scand. J. clin. Lab. Invest 1960; 12(Suppl. 49)
- Odell G. B. The dissociation of bilirubin from albumin and its clinical implications. J. Pediat 1959a; 55: 268
- Andersen H. Studies in kernicterus. I. The protein binding of bilirubin. J. Clin. Invest 1959b; 38: 823
- Andersen H. Protein binding of bilirubin and its possible relationship to kernicterus. J. Dis. Child 1959c; 98: 624
- Ostrow D., Schmid R., Samuelson D. The protein-binding of C11-bilirubin in human and murine serum. J. clin. Invest 1963; 42: 1286
- Pedersen K. O., Waldenström J. Studien über das Bilirubin in Blut und Galle mit Hilfe von Elektrophorese und Ultrazentrifugierung. Hoppe-Seylers Z. physiol. Chem 1937; 245: 152
- Rieder J. Physikalisch-chemische und biologische Untersuchungen an Sulfonamiden. Arznei-mittel-Forsch 1963; 13: 81
- Scholtan W. Vergleichende quantitative Be-stimmung der Eiweissbindung von Chemotherapeutica mittels Sephadex und Dialysis. Arch. intern. Med 1964a; 14: 146
- Andersen H. Die Bindung der Sulfonamide an Eiweisskörper. Arch. intern. Med 1964b; 14: 348
- Silverman W. A., Andersen D. H., Blanc W. A., Crozier D. N. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics 1956; 18: 614
- Speert H. Placental transmission of sulfathiazole and sulfadiazine and its significance for fetal chemotherapy. Amer. J. Obstet. Gynec 1943; 45: 200